Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

If You Can Catch Twilio Stock on the Dip, Buy and Hold

By Chris Lau, InvestorPlace Contributor

Twilio will get to an annualized $1 billion revenue run rate very soon. Consider holding the stock when it gets there.

Not Even FTC Oversight Will Keep Facebook Stock from Cracking $200

By Chris Lau, InvestorPlace Contributor

Facebook faces a big fine from the FTC and yet markets are mostly unfazed. Nothing seems to keep Facebook stock from winning.

Why the Outlook of Roku Stock Is Mixed

By Chris Lau, InvestorPlace Contributor

Roku stock has positive catalysts, but Roku stock price could be victimized by profit-taking going forward.

Should Investors Speculate on Aphria Stock?

By Chris Lau, InvestorPlace Contributor

Aphria stock is down 30%+ in the last quarter, as Aphria stock price fell more than other cannabis stocks. What went wrong for APHA stock?

Why U.S.-China Trade Tensions Pulled Bank of America Stock Lower

By Chris Lau, InvestorPlace Contributor

Bank stocks have fallen as trade war tensions escalated in the last few weeks. Ignore the noise and look at the strengths of BAC stock.

Load More